Amgen Inc. (AMGN)

Current Price: $297.37
Date: July 2, 2025

Amgen Inc. exhibits recent signs of bullish momentum, closing at $297.37 on July 2, 2025. The price has shown significant upward movement, rebounding from previous lows and approaching key resistance levels. Analyzing the latest technical indicators and candlestick patterns provides insights into potential future price movements.

Technical Indicator Summary Table

Moving Averages

The 20-day SMA at $287.52 has recently been overtaken by the price, signaling a bullish tilt in the short-term trend. This positive crossover suggests potential for further upside, with robust support around this level.

The 50-day SMA at $281.68 and 100-day SMA at $292.55 indicate critical medium-to-long-term support zones. Amgen's price is now above these moving averages reflecting an overall bullish sentiment. This surpassing of the 100-day SMA suggests a notable long-term trend reversal favoring upward price movements.

The EMA alignment supports this bullish outlook. The 12-day EMA ($285.82) is above the 26-day EMA ($285.15), displaying a positive cross indicative of renewed bullish momentum. This alignment further confirms that upward trends could persist unless significant resistance levels authorize another reversal.

Relative Strength Index (RSI)

At 61.33, the RSI is approaching the upper sector of the neutral range, suggesting that Amgen is gaining bullish momentum while avoiding overbought conditions. The RSI level permits further price growth while maintaining prudent risk measures against an immediate pullback.

Bollinger Bands

Amgen is trading near the upper Bollinger Band, at $301.90. The current price trajectory towards the upper band underscores the growing bullish sentiment. This signal aligns with increased volatility, often a precursor to substantial price action, either through breakout or reversion to the mean.

If Amgen is able to break the upper band decisively, this move could confirm an ongoing uptrend, putting the price in an advantageous position to challenge fresh highs above $300. Conversely, failure to sustain momentum could signify a return to the middle band ($287.52).

MACD

The MACD line, currently at 0.66, has risen above the signal line, depicting a bullish crossover reinforced by positive histogram readings at 0.30. This trend indicates that buying pressure is consolidating. The consistency of MACD values above the signal line confirms emerging bullish momentum and hints at continued price ascension.

On Balance Volume (OBV)

The OBV stands at -63.85 million, showing decreasing selling pressure and a potential turnaround in net volume trends. The subdued OBV confirms that although broad bullish volume divergences are not yet witnessed, the decelerating downward trend provides vital support for the recent price upticks.

Candlestick Patterns

Recent candlestick patterns, including the July 1, 2025 movement from a low close followed by a strong upward push on July 2nd, mark a reversal pattern that hints at bullishness. The candlestick analysis depicts decisive control by buyers, suggesting this trend may drive the price towards or over the $300 level barring unforeseen resistance.

Summary

Amgen is showing positive indicators on several fronts, with price action breaching significant resistance levels (SMAs) and technical indicators increasingly hinting at bullish continuity. However, momentum sustainability remains critical, particularly around $300, representing both a psychological and technical barrier.

While current indications favor further upside, close monitoring around the $300 level is advised for signs of either breakout or retracement. Traders might anticipate immediate support reinforcement at $292 (100-day SMA) with an optimistic target beyond $305 for bullish continuation, achieving caution below $287 SMA.

Given these metrics, trades should observe stop-loss below $292.55 (100-day SMA) to mitigate reversal risk while targeting above $300 as a high-probability gain in long bias.

**